← back to ranking

ERAS · Erasca, Inc.

Biotechnology · mkt cap $4.2B · calls: Q4 FY2023 vs
3.0 conviction · conf-adj 3

conf – stale 797d

triage_only:3.0

Enthusiasm latest / prev ()

No AI/ML discussion; pure drug development and clinical trial execution